+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Clinical Trial Supply & Logistics for Pharmaceutical Market by Service Type, End User, Phase, Transportation Mode, Temperature Range, Packaging Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989664
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical trial supply and logistics market is transforming as pharmaceutical companies, CROs, and logistics partners respond to rising complexity, evolving trial models, and continuous regulatory shifts. This executive summary distills essential insights for senior stakeholders navigating operational, financial, and strategic decisions in a critical, highly dynamic landscape.

Market Snapshot: Clinical Trial Supply & Logistics Growth

The Clinical Trial Supply & Logistics for Pharmaceutical Market grew from USD 24.48 billion in 2024 to USD 26.45 billion in 2025. It is expected to continue growing at a CAGR of 7.78%, reaching USD 38.37 billion by 2030. This trajectory reflects expanded clinical activity, increased biologics and cell therapies, and more complex trial designs in pharmaceutical R&D.

Scope & Segmentation: Addressing Operational Demands

This report provides a comprehensive analysis of clinical trial supply and logistics, examining critical service offerings, evolving technologies, and distinct regional markets. The segmentation framework captures all major market components for actionable benchmarking and planning:

  • Service Type: Packaging & labeling, project management, storage & distribution, temperature monitoring, transportation.
  • End User: Biotechnology companies, clinical trial sites, contract research organizations, pharmaceutical companies, third-party logistics providers.
  • Trial Phase: Phase I, Phase II, Phase III, Phase IV.
  • Transportation Mode: Air freight (charter, standard), rail freight (direct, intermodal), road freight (FTL, LTL), sea freight (FCL, LCL).
  • Temperature Range: Ambient, controlled room, frozen, refrigerated.
  • Packaging Type: Active packaging (cryogenic shippers, refrigeration units), hybrid packaging (combined solutions, modular systems), passive packaging (insulated boxes, thermal wraps).
  • Region: Americas, Europe/Middle East/Africa, Asia-Pacific—including coverage of leading national markets such as United States, Canada, Brazil, United Kingdom, Germany, China, India, and others.
  • Key Companies: DHL International GmbH, United Parcel Service, Inc., Federal Express Corporation, Thermo Fisher Scientific Inc., Catalent, Inc., PCI Pharma Services, LLC, World Courier, LLC, Marken, Inc., Almac Group Limited, Vetter Pharma-Fertigung GmbH & Co. KG.

Key Takeaways: Strategic Insights for Decision-Makers

  • Growth in decentralized and patient-centric trial models is redefining supply chain protocols and increasing demand for innovative last-mile solutions.
  • Cold chain advancements and real-time digital monitoring now form the backbone of risk mitigation, supporting regulatory compliance and protecting product integrity in wider geographies.
  • Collaboration among logistics specialists, technology firms, and trial sponsors is producing integrated platforms, enhancing supply chain visibility and data-driven decision-making.
  • Regulatory scrutiny is intensifying around digital data security, temperature excursions, and chain-of-custody, compelling sponsors to adopt advanced documentation and packaging technologies.
  • Segment differentiation is clear: biotechnology firms require tailored frameworks for specialty therapies, while clinical sites and CROs focus on streamlined scheduling, flexibility, and reliable handling practices.
  • Regional disparities in infrastructure and guidelines necessitate adaptable logistics models, fostering a move toward local partnerships and shared facilities to boost service reliability.

Tariff Impact: Navigating the 2025 US Trade Landscape

New US tariff regulations introduced in 2025 have added complexity to clinical trial supply operations, affecting procurement, customs management, and pricing strategies. Industry players are reassessing sourcing plans, establishing inventory buffers, and strengthening cost-control measures to address cost volatility and mitigate the risk of supply disruption. Continuous scenario planning and modal diversification, such as shifting shares to overland and sea routes, have emerged as important responses amid evolving tariff rates and compliance burdens. Financial adaptations—including alternative financing structures and flexible vendor terms—are also being used to offset tariff-driven pressures within supply chain workflows.

Methodology & Data Sources

Our analysis is based on extensive secondary research, supported by in-depth interviews with senior executives and subject-matter experts. Quantitative data, including shipment volumes and service utilization rates, is triangulated from databases and industry surveys. The methodology includes multiple validation rounds and peer reviews, ensuring accuracy and relevance of segmentation and regional analysis.

Why This Report Matters: Decision-Driven Outcomes

  • Enables informed strategies for supply chain optimization, compliance, and cost management in a changing regulatory and operational environment.
  • Supports tailored vendor selection, technology adoption, and partnership formation with insights on service segmentation and emerging regional opportunities.
  • Equips senior leaders with actionable forecasts to manage risk, address tariff impacts, and position supply chains for performance and growth.

Conclusion

The clinical trial supply and logistics market is reshaping rapidly amid technological progress, regulatory pressures, and global expansion. Senior decision-makers who adopt integrated, adaptive strategies can seize emerging opportunities and overcome new challenges across regions and service lines.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Service Type
8.1. Introduction
8.2. Packaging & Labeling
8.3. Project Management
8.4. Storage & Distribution
8.5. Temperature Monitoring
8.6. Transportation
9. Clinical Trial Supply & Logistics for Pharmaceutical Market, by End User
9.1. Introduction
9.2. Biotechnology Companies
9.3. Clinical Trial Sites
9.4. Contract Research Organizations
9.5. Pharmaceutical Companies
9.6. Third-Party Logistics Providers
10. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
10.1. Introduction
10.2. Phase I
10.3. Phase II
10.4. Phase III
10.5. Phase IV
11. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Transportation Mode
11.1. Introduction
11.2. Air Freight
11.2.1. Charter
11.2.2. Standard
11.3. Rail Freight
11.3.1. Direct
11.3.2. Intermodal
11.4. Road Freight
11.4.1. Ftl
11.4.2. Ltl
11.5. Sea Freight
11.5.1. Fcl
11.5.2. Lcl
12. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Temperature Range
12.1. Introduction
12.2. Ambient
12.3. Controlled Room
12.4. Frozen
12.5. Refrigerated
13. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Packaging Type
13.1. Introduction
13.2. Active Packaging
13.2.1. Cryogenic Shippers
13.2.2. Refrigeration Units
13.3. Hybrid Packaging
13.3.1. Combined Solutions
13.3.2. Modular Systems
13.4. Passive Packaging
13.4.1. Insulated Boxes
13.4.2. Thermal Wraps
14. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. DHL International GmbH
17.3.2. United Parcel Service, Inc.
17.3.3. Federal Express Corporation
17.3.4. Thermo Fisher Scientific Inc.
17.3.5. Catalent, Inc.
17.3.6. PCI Pharma Services, LLC
17.3.7. World Courier, LLC
17.3.8. Marken, Inc.
17.3.9. Almac Group Limited
17.3.10. Vetter Pharma-Fertigung GmbH & Co. KG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET MULTI-CURRENCY
FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET MULTI-LANGUAGE
FIGURE 3. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STORAGE & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THIRD-PARTY LOGISTICS PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CHARTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STANDARD, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INTERMODAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FTL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY LTL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FCL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY LCL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AMBIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED ROOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CRYOGENIC SHIPPERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REFRIGERATION UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COMBINED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY MODULAR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INSULATED BOXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERMAL WRAPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 89. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 90. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 91. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 92. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 93. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 94. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 95. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 96. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 97. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 98. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 99. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 104. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 105. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 106. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 107. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 110. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 111. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 165. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 166. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 168. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 169. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 170. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 171. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 172. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 173. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 178. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 181. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 182. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 183. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 184. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 185. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 186. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 187. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 188. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 189. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 190. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 204. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 205. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 207. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 208. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 209. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 210. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 211. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 212. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 213. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 214. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 215. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 216. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 217. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 220. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 221. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 222. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 223. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 224. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 225. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 226. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 227. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 228. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 229. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ACTIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY HYBRID PACKAGING, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PASSIVE PACKAGING, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TRANSPORTATION MODE, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY AIR FREIGHT, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY RAIL FREIGHT, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ROAD FREIGHT, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SEA FREIGHT, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Clinical Trial Supply & Logistics for Pharmaceutical market report include:
  • DHL International GmbH
  • United Parcel Service, Inc.
  • Federal Express Corporation
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • PCI Pharma Services, LLC
  • World Courier, LLC
  • Marken, Inc.
  • Almac Group Limited
  • Vetter Pharma-Fertigung GmbH & Co. KG

Table Information